澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LUMOS DIAGNOSTICS HOLDINGS L

0.255

-0.010-3.77%

成交量：1,734.98萬

成交額：466.54萬

市值：2.03億

市盈率：-14.39

高：0.285

開：0.275

低：0.250

收：0.265

52周最高：0.330

52周最低：0.019

股本：7.98億

流通股本：3.76億

量比：10.36

換手率：4.62%

股息：- -

股息率：- -

每股收益(TTM):-0.018

每股收益(LYR):-0.015

淨資產收益率：-123.27%

總資產收益率：-29.18%

市淨率：26.74

市盈率(LYR):-16.61

資料載入中...

總覽公司新聞資訊公告

Lumos Diagnostics Holdings 尋求交易暫停，等待FDA對Febridx CLIA豁免申請的回應更新

Lumos Diagnostics 與 Acuitymd 建立戰略合作，支持 Febridx 檢測在美國的商業化

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LDX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.255,"timestamp":1774588320000,"preClose":0.265,"halted":0,"volume":17349794,"delay":0,"changeRate":-0.03773584905660381,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":797709472,"eps":-0.01771689896103707,"marketStatus":"休市中","change":-0.01,"latestTime":"03-27 16:12:00 AEDT","open":0.275,"high":0.285,"low":0.25,"amount":4665440,"amplitude":0.132075,"askPrice":0.26,"askSize":631542,"bidPrice":0.255,"bidSize":477235,"shortable":3,"etf":0,"ttmEps":-0.01771689896103707,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.265,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":10.357890560597626,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"LDX.AU","preClose":0.265,"auctionPrice":0.255,"auctionVolume":1024116,"auction":3,"marketStatus":"盘后竞价","timestamp":1774588216127}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-29.18%","roe":"-123.27%","lyrEps":-0.015355,"volumeRatio":10.357890560597626,"shares":797709472,"dividePrice":0,"high":0.285,"amplitude":0.132075,"preClose":0.265,"low":0.25,"week52Low":0.019,"pbRate":"26.74","psRate":"11.45","week52High":0.33,"institutionHeld":0,"latestPrice":0.255,"committee":-0.139169,"eps":-0.01771689896103707,"divideRate":0,"volume":17349794,"delay":0,"ttmEps":-0.01771689896103707,"open":0.275,"prevYearClose":0.285,"prevWeekClose":0.26,"prevMonthClose":0.275,"prevQuarterClose":0.285,"fiveDayClose":0.26,"twentyDayClose":0.275,"sixtyDayClose":0.285,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null},{"market":"AU","date":"2023-08-30","symbol":"LDX.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1693317600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1128307929","title":"Lumos Diagnostics Holdings 尋求交易暫停，等待FDA對Febridx CLIA豁免申請的回應更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1128307929","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128307929?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 06:22","pubTimestamp":1774390934,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings（ASX: LDX）已向澳大利亚证券交易所申请交易暂停，以待公司就美国食品药品监督管理局（FDA）对其Febridx检测产品CLIA豁免申请的回应发布最新消息。\n该交易暂停将自2023年10月11日开盘时生效，直至公司发布相关公告或10月13日开盘时终止，以较早者为准。此举旨在确保在重要监管信息发布前，市场交易的公平性和有序性。\nFebridx是公司开发的一款快速诊断产品，CLIA豁免意味着该产品可在更广泛的医疗点（如诊所、药房）由非专业人员使用，从而显著扩大其市场潜力。此次FDA的回应对于该产品在美国的商业化进程至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"1175019599","title":"Lumos Diagnostics 與 Acuitymd 建立戰略合作，支持 Febridx 檢測在美國的商業化","url":"https://stock-news.laohu8.com/highlight/detail?id=1175019599","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175019599?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 05:33","pubTimestamp":1763587990,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics 与 Acuitymd 建立战略合作，支持 Febridx 检测在美国的商业化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}